Colorado EKG Repository

Courtney Kozek, PA-C, Joins Maple Health Direct Primary Care in Mentor

Retrieved on: 
Thursday, September 21, 2023

MENTOR, Ohio, Sept. 21, 2023 /PRNewswire/ -- Developing close connections with patients in a whole-health primary care environment drew Courtney Kozek, PA-C, to join Maple Health DPC in Mentor, Ohio.

Key Points: 
  • MENTOR, Ohio, Sept. 21, 2023 /PRNewswire/ -- Developing close connections with patients in a whole-health primary care environment drew Courtney Kozek, PA-C, to join Maple Health DPC in Mentor, Ohio.
  • Maple Health's direct primary care (DPC) model allows for more quality time with the doctor, longer appointment times and 24/7 access to your physician at the clinic, video, voice, text, or email.
  • P.A.Kozek will join Maple Health DPC beginning October 3rd, but patients may prebook appointments now by calling Maple Health at 440-655-8017.
  • Maple Health DPC is a full-service, membership-based primary care practice that offers flexible access, longer appointment times, less waiting, and a relationship with a doctor you know and trust.

DocGo Announces Record Second Quarter 2023 Results

Retrieved on: 
Monday, August 7, 2023

Total revenue for the second quarter of 2023 was $125.5 million, up from $113.0 million in the first quarter of 2023 and $109.5 million in the second quarter of 2022.

Key Points: 
  • Total revenue for the second quarter of 2023 was $125.5 million, up from $113.0 million in the first quarter of 2023 and $109.5 million in the second quarter of 2022.
  • Gross margin for the second quarter of 2023 was 33.4%, compared to 28.1% in the first quarter of 2023 and 35.9% in the second quarter of 2022.
  • Adjusted EBITDA2 was $9.1 million for the second quarter of 2023 compared to $5.6 million in the first quarter of 2023 and $12.3 million for the second quarter of 2022.
  • Mobile Health revenue for the second quarter of 2023 was $80.1 million, compared to $72.9 million in the first quarter of 2023 and $87.3 million for the second quarter of 2022.

Hepion Pharmaceuticals Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial of Rencofilstat

Retrieved on: 
Thursday, June 15, 2023

This, the first planned DSMB meeting, occurred on schedule, and all labs, EKGs, adverse events, and protocol deviations were reviewed, focusing on any potential safety signals from the placebo-controlled trial.

Key Points: 
  • This, the first planned DSMB meeting, occurred on schedule, and all labs, EKGs, adverse events, and protocol deviations were reviewed, focusing on any potential safety signals from the placebo-controlled trial.
  • Hepion is on track to complete enrollment in ASCEND-NASH in the first quarter of 2024, and the initial subjects are now approaching the later stages of the 12-month trial.
  • “To date we have been pleased with the safety profile for all doses of rencofilstat in both healthy subjects and those with advanced NASH, most recently supported by the lack of safety signals in the 4-month phase 2 ‘ALTITUDE-NASH’ liver function trial,” said Todd Hobbs, MD, Hepion’s Chief Medical Officer.
  • “Having an external group of experts review unblinded safety data from the ongoing and larger ASCEND-NASH biopsy trial and issue this clearance to continue without changes is reassuring for both Hepion and those subjects currently enrolled in the trial.”

Hepion Pharmaceuticals’ Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and Multiple NASH Biomarkers

Retrieved on: 
Monday, May 22, 2023

EDISON, N.J., May 22, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on artificial Intelligence (“AI”)-assisted therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”), and other chronic diseases, today announced positive topline results from its recently completed Phase 2 ALTITUDE-NASH clinical trial.

Key Points: 
  • Other safety labs, EKGs, and physical exams did not reveal any safety signals or concerns over the course of the study.
  • This trial also serves as a bridge to Hepion’s current 12-month Phase 2b ASCEND-NASH liver biopsy-based trial.
  • The test is minimally invasive and is able to sensitively track changes in the degree of liver function impairment.
  • This contrasts with liver biopsy results, which are obtained through a more invasive procedure and only documents liver pathology, not liver function.

Researchers develop first self-healing, electrically conducive, soft material

Retrieved on: 
Thursday, March 9, 2023

This advance, published in Nature Electronics, marks a breakthrough in softbotics and the fields of robotics, electronics, and medicine.

Key Points: 
  • This advance, published in Nature Electronics, marks a breakthrough in softbotics and the fields of robotics, electronics, and medicine.
  • At Carnegie Mellon University, softbotics represents a new generation of soft machines and robots manufactured by multi-functional materials that have integrated sensing, actuation, and intelligence.
  • During the demonstration, the team severed the conductive material and watched as its speed dropped by more than 50%.
  • Because of its self-healing properties, when the material was manually reconnected, the robot restored its electrical connection and recovered 68% of its original speed.

MyDoc Urgent Care Expands Telemedicine Services to Reach More Patients

Retrieved on: 
Friday, February 24, 2023

New York, New York--(Newsfile Corp. - February 24, 2023) - MyDoc Urgent Care is pleased to announce its telemedicine 7-days-a-week healthcare services.

Key Points: 
  • New York, New York--(Newsfile Corp. - February 24, 2023) - MyDoc Urgent Care is pleased to announce its telemedicine 7-days-a-week healthcare services.
  • The newly launched services include emergency medicine, COVID and Flu testing, gynecology and pain medicine, telemedicine, and other types of emergency care.
  • The company is excited to inform residents in New York that in addition to providing comprehensive 7-days-a-week emergency care services, the clinic's telemedicine services have also now added a walk-in gynecology services division.
  • MyDoc Urgent Care is founded by Dr. Nabil Salib, who works diligently to provide comprehensive, compassionate, and personalized medical care to patients of all ages.

CURE Medical Center to Add Vironix AI-Preventative Care Technology to Chronic & Concierge Care Services

Retrieved on: 
Wednesday, November 16, 2022

Key Points: 
  • CURE / Malibu Medical Group is utilizing Vironix Health 's AI- Enabled Remote Patient Care Productsto improve chronic disease management and promote preventative care in Southern California.
  • CURE medical center, under the leadership of renowned medical expert Dr. Lisa Benya, has grown into one of the largest Southern California treatment centers supporting over 2,000 patients with primary care, chronic care, nutrition, mental health, fitness, skin care, and other services.
  • Dr. Lisa Benya , CoFounder & Director at CURE said, "Our team is excited to add a layer of smart technology to our preventative care services.
  • CURE concierge is a members-only club with boutique concierge medical services, fitness, and self-care.

Microcontroller Will be $43.61 Billion Market by 2030, Says P&S Intelligence

Retrieved on: 
Wednesday, October 26, 2022

NEW YORK, Oct. 26, 2022 /PRNewswire/ --In 2021, the global microcontroller market accounted for $18.80 billion, which is set to touch a $43.61 billion value by 2030, advancing at a 9.8% CAGR from 2021 to 2030, according to the latest market research study published by P&S Intelligence.

Key Points: 
  • NEW YORK, Oct. 26, 2022 /PRNewswire/ --In 2021, the global microcontroller market accounted for $18.80 billion, which is set to touch a $43.61 billion value by 2030, advancing at a 9.8% CAGR from 2021 to 2030, according to the latest market research study published by P&S Intelligence.
  • Get the sample pages of this report: https://www.psmarketresearch.com/market-analysis/microcontroller-market/...
    Based on product, 32-bit microcontrollers will advance with an over 10% CAGR in the coming years.
  • Similarly, 8-bit microcontroller sales will advance at a rapid pace, primarily ascribed to their growing adoption in connected peripherals and smart wearables.
  • Browse detailed report on Microcontroller Market Size, Share and Growth Analysis Report 2022-2030
    How Are Increasing Automobile SalesEncouraging Demand for Microcontrollers in APAC?

Microcontroller Will be $43.61 Billion Market by 2030, Says P&S Intelligence

Retrieved on: 
Wednesday, October 26, 2022

NEW YORK, Oct. 26, 2022 /PRNewswire/ --In 2021, the global microcontroller market accounted for $18.80 billion, which is set to touch a $43.61 billion value by 2030, advancing at a 9.8% CAGR from 2021 to 2030, according to the latest market research study published by P&S Intelligence.

Key Points: 
  • NEW YORK, Oct. 26, 2022 /PRNewswire/ --In 2021, the global microcontroller market accounted for $18.80 billion, which is set to touch a $43.61 billion value by 2030, advancing at a 9.8% CAGR from 2021 to 2030, according to the latest market research study published by P&S Intelligence.
  • Get the sample pages of this report: https://www.psmarketresearch.com/market-analysis/microcontroller-market/...
    Based on product, 32-bit microcontrollers will advance with an over 10% CAGR in the coming years.
  • Similarly, 8-bit microcontroller sales will advance at a rapid pace, primarily ascribed to their growing adoption in connected peripherals and smart wearables.
  • Browse detailed report on Microcontroller Market Size, Share and Growth Analysis Report 2022-2030
    How Are Increasing Automobile SalesEncouraging Demand for Microcontrollers in APAC?

vybe urgent care Announces Its 15th Location - Radnor

Retrieved on: 
Monday, October 17, 2022

vybe's 15th urgent care center is located on Lancaster Avenue in the Radnor Hotel complex, at the intersection of Radnor-Chester Road.

Key Points: 
  • vybe's 15th urgent care center is located on Lancaster Avenue in the Radnor Hotel complex, at the intersection of Radnor-Chester Road.
  • Consumers rely on vybe urgent care centers for walk-in convenience, but vybe also offers appointments for all urgent care services.
  • vybe urgent care is Philadelphia's leading independent urgent care provider delivering care to adults and children in Philadelphia, Delaware, Bucks and Montgomery Counties.
  • vybe is fully accredited by the Urgent Care Association (UCA), which is the highest level of distinction for urgent care centers and ensures high levels of patient safety and quality.